Literature DB >> 31662393

Lifestyle behaviour change for preventing the progression of chronic kidney disease: a systematic review.

Nicole Evangelidis1,2, Jonathan Craig2,3, Adrian Bauman4, Karine Manera4,2, Valeria Saglimbene4,2, Allison Tong4,2.   

Abstract

OBJECTIVES: Modifying lifestyle can prevent the progression of chronic kidney disease (CKD) but the specific elements which lead to favourable behaviour change are not well understood. We aimed to identify and evaluate behaviour change techniques and functions in lifestyle interventions for preventing the progression of CKD.
DESIGN: Systematic review. DATA SOURCES: MEDLINE, EMBASE, CINAHL and PsycINFO. ELIGIBILITY CRITERIA: Trials of lifestyle behaviour change interventions (including diet, physical activity, smoking and/or alcohol) published to September 2018 in adults with CKD stages 1-5. DATA EXTRACTION AND SYNTHESIS: Trial characteristics including population, sample size, study setting, intervention, comparator, outcomes and study duration, were extracted. Study quality was independently assessed by two reviewers using the Cochrane risk of bias tool. The Behaviour Change Technique Taxonomy v1 was used to identify behaviour change techniques (eg, goal setting) and the Health Behaviour Change Wheel was used to identify intervention functions (eg, education). Both were independently assessed by three reviewers.
RESULTS: In total, 26 studies involving 4263 participants were included. Risk of bias was high or unclear in most studies. Interventions involved diet (11), physical activity (8) or general lifestyle (7). Education was the most frequently used function (21 interventions), followed by enablement (18), training (12), persuasion (4), environmental restructuring (4), modelling (2) and incentivisation (2). The most common behaviour change techniques were behavioural instruction (23 interventions), social support (16), behavioural demonstration (13), feedback on behaviour (12) and behavioural practice/rehearsal (12). Eighteen studies (69%) showed a significant improvement in at least one primary outcome, all of which included education, persuasion, modelling and incentivisation.
CONCLUSION: Lifestyle behaviour change interventions for CKD patients frequently used education, goal setting, feedback, monitoring and social support. The most promising interventions included education and used a variety of intervention functions (persuasion, modelling and incentivisation). PROSPERO REGISTRATION NUMBER: CRD42019106053. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Behaviour Change Technique Taxonomy v1; behaviour change techniques; chronic kidney disease (CKD); diet; exercise; health behaviour change wheel; lifestyle; systematic review

Year:  2019        PMID: 31662393      PMCID: PMC6830616          DOI: 10.1136/bmjopen-2019-031625

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


We used comprehensive, evidence-based frameworks to identify and describe behaviour change techniques and intervention functions in lifestyle behavioural interventions for patients with chronic kidney disease. Coding of behaviour change techniques and intervention functions was systematically and independently conducted by three researchers, and risk of bias was assessed. Summary estimates could not be ascertained due to the heterogeneity of interventions and outcome measures.

Introduction

Preventing the progression of chronic kidney disease (CKD) is a high priority for patients and clinicians, to reduce the requirement for dialysis.1–3 Lifestyle interventions which modify behavioural risk factors such as poor diet and low physical activity can prevent progression of CKD and life-threatening complications and improve quality of life and survival.4–6 Addressing behaviour change is particularly relevant in CKD as lifestyle modification can be challenging. Poor adherence to diet, medication and other treatments is common in CKD.7 Barriers to modifying lifestyle include low health literacy, conflicts with cultural norms, complicated nutritional requirements and safety concerns.7–11 Guidelines recommend the explicit use of behaviour change for addressing lifestyle risk factors when designing and reporting interventions for patients with CKD.12 13 However, it is uncertain which aspects of lifestyle behaviour change interventions are the most effective, and reporting of behavioural components is often unclear, making implementation in practice problematic. The Behaviour Change Technique Taxonomy v1 was developed to provide a comprehensive framework that integrates behaviour change techniques used in interventions.14 The Taxonomy was further synthesised into a framework, the Health Behaviour Change Wheel which describes the intervention functions necessary to change health behaviours.15 The Health Behaviour Change Wheel provides a broad, overarching framework in which to characterise behaviour change interventions while the Taxonomy identifies specific techniques related to individual behaviours. The intervention functions described in the Health Behaviour Change Wheel can be delivered by a variety of behaviour change techniques. For example, the intervention function, ‘education’, outlined in the Wheel, can include the behaviour change techniques ‘instruction on how to perform the behaviour’ and ‘information about antecedents’, detailed in the Taxonomy. Similarly, the intervention function ‘incentivisation’ can incorporate techniques such as ‘feedback on behaviour’ and ‘rewards’. Behaviour change interventions using the Wheel and the Taxonomy can effectively change lifestyle behaviours. For example, a text-messaging and pedometer programme improved physical activity in people at high risk of type 2 diabetes,16 a digital healthy eating programme increased consumption of fruit and vegetables and sustained this over a 6-month period17 and a digital behaviour change programme achieved significant weight loss results in individuals at risk of type 2 diabetes.18 The Taxonomy and the Wheel are recommended approaches to modify lifestyle risk factors for chronic disease prevention.12 16 18 However, these frameworks have not been used in designing and reporting behaviour change strategies in lifestyle interventions for patients with CKD. We aimed to identify and evaluate behaviour change techniques and intervention functions used in lifestyle interventions for preventing the progression of CKD. This may inform the development of effective and replicable behaviour change interventions for the prevention of CKD, leading to improvements in patient outcomes.

Methods

We used the Preferred Reporting Items for Systematic Reviews and Meta-analyses Statement19 and checklist to report this systematic review (online supplementary file S1).

Selection criteria

We included randomised trials of lifestyle behaviour change interventions (including, but not restricted to diet, physical activity, smoking and alcohol consumption) in adult patients (aged over 18 years) with CKD stages 1–5 and not requiring renal replacement therapy. We did not apply restrictions based on outcomes or language. Studies including a combination of pharmacological therapy and lifestyle were included but trials involving only pharmacological therapies were excluded.

Literature search

A comprehensive search was conducted in MEDLINE (1946 to 20 September 2018), EMBASE (1996 to 20 September 2018), CINAHL (1982 to 20 September 2018) and PsycINFO (1806 to 20 September 2018) using Medical Subject Heading (MeSH) terms relating to CKD, and lifestyle behaviour change interventions (online supplementary file S2), and reference lists of relevant articles and reviews. Author NE screened the studies by title and abstract and assessed full-text articles for eligibility. Those that did not meet the inclusion criteria were excluded.

Data extraction and critical appraisal

The trial characteristics relevant to the population, sample size and study setting as well as intervention (type, mode of delivery, use of theory, intervention functions (as described in the Health Behaviour Change Wheel15 and behaviour change techniques (as described in the Behaviour Change Technique Taxonomy v114)), comparator, outcomes and study duration, were extracted and tabulated. We assessed the risk of bias using the Cochrane tool for randomised studies.20 NE and KM assessed the risk of bias in each study independently and any differences were resolved by discussion. We contacted the authors of the studies when it was necessary to gather additional information. Supplemental data was available in 12 of the 26 studies. In six studies with no supplemental data, sufficient information was available in the published article. Therefore, we contacted eight authors to request further information and received responses from two authors.

Analysis of intervention functions and behaviour change techniques

The Behaviour Change Technique Taxonomy v1 (the ‘Taxonomy’) and Health Behaviour Change Wheel (the ‘Wheel’) are comprehensive tools for identifying behavioural components in interventions and how frequently they occur.14 15 The two frameworks are complementary and in addition to designing interventions, they have been used as a method for identifying behavioural components in public health interventions and clinical trials.21 The tools have been used in previous systematic reviews to identify behaviour change techniques and functions in health interventions.22–28

Behaviour change techniques

The Behaviour Change Technique Taxonomy consists of 93 behaviour change techniques, such as goal-setting, self-monitoring, social support and re-structuring the physical environment (see online supplementary table S1 for the full taxonomy). The techniques are grouped into 16 domains: goals and planning, feedback and monitoring, social support, shaping knowledge, natural consequences, comparison of behaviour, associations, repetition and substitution, comparison of outcomes, reward and threat, regulation, antecedents, identity, scheduled consequences, self-belief and covert learning.

Intervention functions

There are nine intervention functions in the Wheel: education, persuasion, incentivisation, coercion, training, enablement, modelling, environmental restructuring and restrictions.15 These are activities designed to change behaviours and include one or more behaviour change techniques. Definitions of each intervention function have been described by Michie et al and were used to inform decisions about what functions were present in each study.15 Authors NE and KM completed online training for interpreting the Wheel and the Taxonomy to ensure consistency and reliability of coding.29 N.E, KM and VS independently read intervention descriptions line-by-line to locate text matching a definition of an intervention function15 and the description of behaviour change techniques from the BCTTv1 coding frame (online supplementary table S1). Each of the 93 behaviour change techniques were indicated as either present or absent in a standardised data extraction form. A behaviour change technique had to be explicitly described to be coded and included in the analysis. The authors compared the codes and discussed discrepancies to reach consensus.

Patient and public involvement

No patient involved.

Results

Literature search and study characteristics

The literature search yielded 10 043 citations from which 26 studies (n=4263 participants) were eligible and included in the review (figure 1). Study characteristics are shown in table 1. The studies were conducted in 15 countries.
Figure 1

PRISMA flowchart of included/excluded studies. *A behavioural intervention explicitly describes a behaviour change technique which can be coded using the Behavior Change Technique Taxonomy v1. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analyses.

Table 1

Characteristics of included studies

StudyNCKD StageAge (years)CountryInterventionComparatorPrimary OutcomesStudy duration (months)
Dietary interventions
Campbell et al 38 56CKD4–5>18AustraliaIndividualised nutritional counselling and regular follow-upUsual careBody composition3
Clark et al 47 590CKD318–80CanadaCoaching to increase water intake (drinking containers and water vouchers also provided)Coaching to maintain usual fluid intakeChange in eGFR12
De Brito-Ashurst et al 37 56eGFR <60 mL and BP >130/80 or taking BP medication; Bangladeshi origin18–74United KingdomCommunity cooking education sessions facilitated by Bengali workersUsual careReduction in systolic/diastolic BP6
Dussol et al 61 63Type I/II diabetic nephropathy, eGFR60-100 mL40–72FranceLow-protein diet with telephone calls every 6 weeks to help change dietary habitsUsual-protein dietDecline GFR and 24-hour albumin excretion rate24
MDRD Study (1995)*840eGFR 13–55 mL18–70United StatesLow protein diet with dietician supportModerate, low and very low protein diets comparedDecline eGFR, dietary satisfaction45
Mekki et al 62 40eGFR 60–90 mL47–75AlgeriaNutritional advice based on Mediterranean dietUsual careDyslipidaemia3
Meuleman et al 32 138eGFR ≥20 mL≥18The NetherlandsSodium restricted diet with self-management, education, motivational interviewing and self-monitoringUsual careSodium excretion & BP3
Paes-Barreto et al 46 89CKD3–5≥18BrazilIntense counselling/education on low protein dietStandard counsellingChange in protein intake4
Pisani et al 42 57CKD3b–5>18ItalyLow protein, phosphate and sodium diet, ‘6-tips diet’ checklistNon-individualised, moderately low protein dietProtein intake, metabolic parameters and adherence6
Rosman e t al 63 247CrCl 10–60 mL/min15–73The NetherlandsDietary protein restriction and dietician visits every 3 monthsUsual careAdherence24
Saran e t al 64 58CKD3–4>18United StatesDietary sodium restriction (<2 g sodium per day)Usual dietChange in hydration status1
Physical activity interventions
Aoike et al 59 29CKD3–418–70BrazilHome-based moderate-intensity aerobic exercise programmeUsual careCardiopulmonary/functional, BP, CrCl, eGFR3
Barcellos et al 65 150CKD2–4>18BrazilAerobic and resistance trainingUsual careChange in eGFR4
Greenwood et al 43 20CKD3–418–80United KingdomResistance and aerobic training (3 days per week)Usual careChange in eGFR12
Kao et al 30 94eGFR ≥15 mL≥39TaiwanGroup education lecture; individual exercise programme Trans-Theoretical ModelNot specifiedExercise behaviour, depression, fatigue3
Leehey et al 66 32CKD2–449–81United StatesAerobic & resistance training, home exercise (plus dietary management)Dietary managementUrine protein to creatinine ratio12
Rossi et al 45 107CKD3–4≥18United StatesGuided exercise twice a week plus usual careUsual carePhysical function, quality of life3
Tang et al 49 90CKD1–318–70ChinaIndividualised exercise programme (education and home-based aerobic exercise)Usual carePhysical function, self-efficacy, anxiety, depression, quality of life3
Van Craenenbroeck et al 34 40CKD3–4≥18BelgiumHome-based aerobic training programme (four daily cycling sessions, 10 min each)Usual carePeripheral endothelial function3
Lifestyle interventions
Flesher et al 39 40CKD3–418–80CanadaIndividual dietary counselling, group nutrition and cooking classes, exercise programmeUsual careComposite eGFR, TC, urinary sodium, urinary protein and BP12
Howden et al 40 83CKD3–418–75AustraliaMulti-disciplinary care, lifestyle and aerobic/resistance trainingUsual careChange in CRF12
Ishani et al 41 601eGFR <60>18USACare by a multi-disciplinary team using a telehealth deviceUsual careComposite death, hospitalisation, emergency visits and admission to a nursing facility20
Jiamjariyapon et al 67 442CKD3–418–70ThailandIntegrated care by multi-disciplinary team and community care workers. Group counselling, home visitsUsual careChange in eGFR24
Joboshi and Oka44 65Overt proteinuria and clinically diagnosed CKD38–86JapanSelf-management programmeStandard educationSelf-efficacy and self-management behaviour3
Patil et al 68 76 Diabetic nephropathy30–70IndiaLow-calorie diet, physical activity and behaviourACE inhibitor therapy24-hour urine protein BMI6
Teng et al 31 160eGFR ≥30 mL/min/1.73 m2 ≥20TaiwanLifestyle modification programme based on Trans-Theoretical ModelStandard educationHealth behaviours, knowledge, physical function12

*MDRD study described in two main articles: Gillis et al 33 and Coyne et al 48.

BMI, Body Mass Index; BP, blood pressure;CKD, chronic kidney disease; CrCl, creatinine clearance; CRF, cardiorespiratory fitness; eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease study; TC, total cholesterol.

PRISMA flowchart of included/excluded studies. *A behavioural intervention explicitly describes a behaviour change technique which can be coded using the Behavior Change Technique Taxonomy v1. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analyses. Characteristics of included studies *MDRD study described in two main articles: Gillis et al 33 and Coyne et al 48. BMI, Body Mass Index; BP, blood pressure;CKD, chronic kidney disease; CrCl, creatinine clearance; CRF, cardiorespiratory fitness; eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease study; TC, total cholesterol.

Risk of bias assessment

Overall, the reporting of studies was relatively incomplete, particularly for the blinding of participants and personnel which was missing or unclear in every study (figure 2). Allocation concealment was unclear or at high risk of bias in 20 (77%) studies. Blinding of outcome assessment was also poorly reported with 19 studies showing high or unclear risk of bias for this domain. Domains that performed better were selective reporting with low risk of bias in 21 studies, random sequence generation with low risk of bias in 17 studies and incomplete outcome data showing low risk of bias in 13 studies.
Figure 2

Risk of bias for individual studies (n=26). MDRD, Modification of Diet in Renal Disease study.

Risk of bias for individual studies (n=26). MDRD, Modification of Diet in Renal Disease study.

Characteristics of the interventions

Across the interventions assessed in the 26 studies included, 11 were dietary interventions, 8 involved physical activity and 7 used any combination of diet, physical activity, weight reduction and/or smoking cessation (lifestyle). Five studies were informed by theory, three used the Trans-Theoretical Model,30 31 one used self-regulation theory32 and another was informed by contemporary behavioural theory, in particular the self-management approach.33 Two studies used Motivational Interviewing,34 35 a counselling approach which involves behaviour change strategies.36 Only three studies included family members, friends or partners in the intervention to facilitate participant’s behaviour change (online supplementary table S2).31 37 Table 2 outlines the number of behaviour change techniques present in each lifestyle behaviour change intervention. The number of behaviour change techniques used across interventions ranged from two to 20.
Table 2

Cross matrix of behaviour change techniques and lifestyle behaviour change trials

Meuleman et al 32 MDRD Study (1995)*De Brito-Ashurst et al 37 Paes-Barreto et al 46 Campbell et al 38 Rosman et al 63 Dussol et al 61 Pisani et al 42 Saran et al 64 Clark et al 47 Mekki et al 62 Tang et al 49 Kao et al 30 Greenwood et al 43 Rossi et al 45 Aoike et al 59 Barcellos e t al 65 Van Craenenbroeck et al 34 Leehey et al 66 Howden et al 40 Ishani et al 41 Joboshi and Oka44 Teng et al 31 Flesher et al 39 Jiamjariyaponet al 67 Patil et al 68
DietPhysical ActivityLifestyle
1.Goals and planning
1.1. Goal setting (behaviour)
1.2. Problem solving
1.3. Goal setting (outcome)
1.4. Action planning
1.5. Review behaviour goal(s)
1.7. Review outcome goal(s)
1.8. Behavioural contract
1.9. Commitment
2.Feedback and monitoring
2.1. Monitoring of behaviour by others without feedback
2.2. Feedback on behaviour
2.3. Self-monitoring of behaviour
2.4. Self-monitoring of outcome(s) of behaviour
2.6. Biofeedback
2.7. Feedback on outcome(s) of behaviour
3. Social support
3.1. Social support (unspecified)
3.2. Social support (practical)
3.3. Social support (emotional)
4. Shaping knowledge
4.1. Instruction on behaviour
4.4. Behavioural experiments
5.Natural consequences
5.1. Information about health consequences
5.2. Salience of consequences
5.4. Monitoring of emotional consequences
6.Comparison of behaviour
6.1. Demonstration of the behaviour
6.2. Social comparison
7.Associations
7.1. Prompts/cues
8.Repetition and substitution
8.1. Behavioural practice/rehearsal
8.2. Behaviour substitution
8.4. Habit reversal
8.6. Generalisation of target behaviour
8.7. Graded tasks
9.Comparison of outcomes
9.2. Pros and cons
10.Reward and threat
10.3. Non-specific reward
10.4. Social reward
10.10. Reward (outcome)
11.Regulation
11.2. Reduce negative emotions
11.3. Conserving mental resources
12.Antecedents
12.5. Adding objects to the environment
15.Self-belief
15.1. Verbal persuasion capability
15.3. Focus on past success
Number of BCTs 20 18 12 9 7 6 4 4 4 2 2 14 11 9 7 6 6 4 2 9 7 7 7 6 4 4

*MDRD study described in two main articles: Gillis et al 33 and Coyne et al 48.

BCT, Behaviour Change Technique.

Cross matrix of behaviour change techniques and lifestyle behaviour change trials *MDRD study described in two main articles: Gillis et al 33 and Coyne et al 48. BCT, Behaviour Change Technique. The top five most frequently observed behaviour change techniques were instruction on how to perform the behaviour (23 interventions, 88%), social support (16, 62%), demonstration of the behaviour (13, 50%), feedback on behaviour (12, 46%) and behavioural practice/rehearsal (12, 46%). Of the 93 possible behaviour change techniques that could have been used, 12 techniques were used in more than 20% of trials, 27 were used at least once and 54 were never used. The mean number of behaviour change techniques was 5, the median was four and the range 2–20. The two studies with the highest number of behaviour change techniques (20 and 18 in each study) were both informed by theory, with a particular focus on self-regulation and self-management.32 33 Table 3 lists the intervention functions present in each study (education, enablement, training, persuasion, modelling, incentivisation, environmental restructuring, coercion and restrictions). The number of functions used across interventions ranged from one to seven.
Table 3

Cross matrix of intervention functions and lifestyle behaviour change trials

Intervention functions
Studies Type of intervention Education Enablement Training Persuasion Environmental restructuring Modelling Incentivisation
Campbell et al 38 Diet
Clark et al 47
De Brito-Ashurst et al 37
Dussol et al 61
MDRD Study (1995)*
Mekki et al 62
Meuleman et al 32
Paes-Barreto et al 46
Pisani et al 42
Rosman et al 63
Saran et al 64
Aoike et al 59 Physical Activity
Barcellos et al 65
Greenwood et al 43
Kao et al 30
Leehey et al 66
Rossi et al 45
Tang et al 49
Van Craenenbroeck et al 34
Flesher et al 39 Lifestyle
Howden et al 40
Ishani et al 41
Jiamjariyapon et al 67
Joboshi44
Patil et al 68
Teng et al 31
Total 21 18 12 4 4 2 2

*MDRD study described in two main articles: Gillis et al 33 and Coyne et al.48

Education

Education was used most frequently as an intervention function, present in 21 (81%) interventions (table 3). Examples of educational strategies were: nutritional label reading,38 39 a resistance training booklet for home-based exercise,40 a lecture/workshop about exercise recommendations with demonstrations,30 online education modules on lifestyle modification41 and a written ‘six-tip diet’ checklist.42 Cross matrix of intervention functions and lifestyle behaviour change trials *MDRD study described in two main articles: Gillis et al 33 and Coyne et al.48

Enablement

Eighteen (69%) interventions used enablement. Examples include Motivational Interviewing to improve self-management of diet, lifestyle and physical activity,32 43 supportive telephone calls matching stages of behaviour change,30 self-management techniques to foster self-efficacy38 39 44 and arranging support from friends and family members and ‘buddy’ visits.31 33 Four interventions were specifically designed using a self-management approach and assessed self-efficacy as an outcome.32 33 39 44

Training

Twelve (46%) interventions included training as an intervention function. Training was used in every intervention targeting physical activity but only used in two dietary interventions and two lifestyle interventions. Examples of training include home-based exercise training, guided exercise training in a gym,40 physical therapy or cardiac rehabilitation facility45 or hospital34 and interactive cooking classes.39

Persuasion

Four (15%) interventions used persuasion as an intervention function. A dietary intervention aimed to persuade participants about dietary salt intake by displaying test tubes of salt content alongside a range of high-salt food items.46 In another dietary intervention, positive thinking was applied to participant’s goals and dieticians praised progress and focused on positive results.33 Similarly, a lifestyle intervention used positive reinforcement to increase confidence and celebrate successes related to behaviour change and also discussed lack of exercise, poor dietary habits, risks of not exercising and associated consequences.31 Only one physical activity intervention used persuasion in designing and displaying printed health messages to promote exercise.30

Environmental re-structuring

Four (15%) interventions used environmental restructuring. Two involved placing exercise equipment in the home environment (exercise bicycle, Theraband, weights and Swiss ball)40 43 and two included adding food products and equipment into the home environment (low sodium/protein meals and water bottles).33 47

Modelling

Two (8%) dietary interventions incorporated modelling as an intervention function. Educators used food models and household measuring utensils to model appropriate food portion sizes46 and food tastings provided an example of low protein meals.33

Incentivisation

Two (8%) studies used incentivisation, one in the form of ‘appreciation gifts’ including certificates and mugs33 and another included ‘self-rewards’ chosen by participants.32

Coercion and restrictions

These functions were not used in any of the interventions.

Outcomes

A description of primary outcomes and results reported in studies is included in table 4. Primary outcomes of studies in this review were diverse and were mainly physiological metrics (for example, eGFR, blood pressure, peak VO2 and sodium or albumin excretion). Only six studies included patient-reported and/or behavioural primary outcomes such as quality of life, fatigue, knowledge, self-efficacy, self-management, exercise and health behaviours.30 31 44 45 48 49
Table 4

Effects of the behaviour change interventions on the primary outcome(s)

StudyPrimary outcome/sMeasuresIntervention (n)Control (n)Intervention*Control*Mean difference (95% CI)P value
Dietary interventions
Campbell et al 38 Body compositionBody cell mass, %29272.0 (1.9 to 5.9)†1.5 (5.5 to 2.5)†3.5 (2.1 to 9.1)0.2
Body cell mass, kg0.5 (1.8 to 0.8)†0.5 (0.7 to 1.8)†1.1 (0.7 to 2.9)0.2
Clark et al 47 Change in eGFRChange eGFR, mL/min/1.73 m2 311308−2.2 (−3.3 to −1.1)†−1.9 (−2.9 to −0.9)†−0.3 (−1.8 to 1.2)0.74
De Brito-Ashurst et al 37 Change in BPReduction systolic/diastolic BP2523−8 mm Hg (−11 to −5)/2 (−4 to −2)<0.001
Dussol et al 61 Decrease in eGFRDecrease eGFR, mL/min/1.73 m2 2522−7±11−5±15
24-hour albumin excretion rateMicroalbuminuria, mg/d+114±364+156±486
MDRD‡ Study 1 (1995)Dietary satisfaction (Study A: GFR 25–55 mL/min. 1.73m2)Dietary satisfaction score2202213.6±1.03.8±1.0<0.05
Dietary satisfaction (Study B: GFR 13–24 mL/min. 1.73m2 Dietary satisfaction score65593.1±0.93.6±0.9<0.01
MDRD‡ Study 2 (1996)Decline eGFR (Study A: GFR 25–55 mL/min. 1.73m2)Decline eGFR, baseline to 3 years2913943.8 (4.2)§
Decline eGFR (Study B: GFR 13–24 mL/min. 1.73m2)Decline eGFR, baseline to 3 years1261294.0 (3.1)§
Mekki et al 62 Total cholesterol (TC)TC/mmol L-120204.1±0.55.4±0.4<0.05
Triacylglycerols (TG)TG/mmol L-12.9±0.13.9±0.1<0.05
Meuleman et al 32 Blood pressureOffice systolic BP, mmHg6771−7.3 (−12.7 to −1.9)¶<0.01
Office diastolic BP, mmHg−3.8 (-6.9 to -0.6) <0.05
Sodium excretionSodium excretion rate, mmol/24 hours2.9 (−21.6 to 27.3)
Paes-Barreto et al 46 Change in protein intakeChange protein intake, g/day4346−20.7 (−30.9%)††−10.5 (−15.1%)¶†† 0.04
Pisani et al 42 Protein intakeChange protein intake, g/kg/day2727−0.1 (−0.17 to −0.03)†−0.2 (−0.28 to −0.13)†0.04
UUN excretionChange UUN, g/day−1.3 (−2.1 to −0.5)†−2.8 (−3.6 to −2)†0.008
SUNChange SUN, mg/dL2.96 (−7.71 to 13.64)†−16.63 (−27.3 to −5.96)†0.012
Urinary phosphate excretionChange phosphate excretion, mg/day−27.6 (−93.7 to 38.4)†−165.3 (−231.3 to −99.2)†0.005
Serum phosphate concentrationChange serum phosphate, mg/dL0.2 (0 to 0.4)†−0.1 (−0.3 to 0.2)†0.093
AdherenceMet criteria, n, %19 (70%)‡‡11 (44%)‡‡
Rosman et al 63 Adherence (Group A1 & B: CrCl >30)Median 24-hour urea excretion mmol/24 hours4547<0.01
Adherence (Group A2 & C: CrCl ≤30)Median 24-hour urea excretion mmol/24 hours2317<0.01
Saran et al64 Change hydration statusExtracellular Volume, L2929−1.02 (−1.48 to 0.56)<0.001
Intracellular Volume, L−0.06 (−0.12 to 0.01)0.02
Physical activity interventions
Aoike et al 59 CardiopulmonaryMaximal ventilation, L/min141590.7±28.176.6±23.30.003
parametersVentilatory threshold, VO2 peak, ml/kg/min26.1±7.024.2±7.10.302
VO2 in respiratory compensation point, ml/kg/min21.7±5.519.0±5.60.073
Speed in respiratory compensation point, Km/h6.8±1.15.8±1.0<0.001
Functional capacity6MWT, minutes583.1±85.2561.2±91.20.028
Time up/go test, seconds5.82±1.396.42±1.110.001
Arm curl test, repetitions22.8±4.818.1±3.1<0.001
STST, repetitions24.0±7.118.3±4.8<0.001
2-minute step test, steps219.3±36.7179.9±36.3<0.001
Back scratch test, cm6.4±6.612.6±9.90.05
Systolic and diastolic BPSystolic BP, mm Hg118.7±7.3126.8±6.70.012
Diastolic BP, mm HgP76.1±4.481.0±3.70.038
Renal functionSerum creatinine, mg/dL2.6±1.13.2±1.40.215
eGFR, mL/min/1.73 m2 31.9±13.723.9±12.20.046
Barcellos et al 65 Mean change in eGFRChange eGFR, mL/min/1.73 m2 767461.5 (57.0 to 66.1)†59.0 (54.2 to 63.8)†0.7 (−4.0 to 5.4)
Greenwood et al 43 Mean change in eGFRChange eGFR, mL/min/1.73 m2 810−3.8±2.8−8.5±6.47.8±3.0 (1.1 to 13.5)0.02
Kao et al 30 DepressionChange depression (Beck Depression Inventory-II scale)4549−3.71§§1.33§§<0.01
FatigueChange fatigue−4.74§§ 1.91§§ <0.001
Exercise behaviourChange weekly exercise4.28§§ −1.24§§ <0.001
Leehey et al66 UPCR ratioUPCR (mg/g) at 52 wks1418405 (225 to 1038)††† 618 (323 to 1155)††† 0.39
Rossi et al 45 Physical function6MWT, minutes5948210.4±266−10±219.9<0.001
STST, seconds26.9%±27% age prediction***0.7%±12.1% age prediction*** <0.001
Gait speed, cm9.5 (−36.4 to 34)††† 0 (−9 to 13)††† 0.76
QoL (RAND SF-36),Role functioning/physical19.0±31.7−8.9±38.4<0.001
mean change fromPhysical functioning11.1±19.3−0.7±18.70.004
baselineEnergy/fatigue9.8±17.60.5±18.00.01
General health4.9±15.3−1.2±11.50.03
Pain5.7±20.0−3.8±24.40.04
Emotional well-being4.2±16.9−0.4±17.10.2
Social functioning4.2±20.81.6±22.60.57
Role functioning/emotional6.9±24.51.9±29.20.38
Tang et al 49 Physical functionChange 6MWT, minutes424241.93±14.57−5.05±14.81<0.001
Change STST, seconds−2.68±1.950.49±2.07<0.001
Self-efficacyChange self-efficacy score6.64±6.92−3.72±6.80<0.001
AnxietyChange HAD-A score−1.02±1.470.21±2.170.003
DepressionChange HAD-D score−0.76±1.320.31±1.840.003
QoL (KDQOL-SF),Symptom/problem list2.49±4.810.38±6.970.007
mean change fromEffects of kidney disease1.90±5.22−1.56±9.640.005
baselineBurden of kidney disease−0.45±15.27−15.3±18.11<0.001
SF-12 PCS1.08±3.60−0.74±4.550.045
SF-12 MCS1.87±5.69−0.73±4.530.002
Van Craenenbroeck et al 34 Peripheral endothelial functionFlow mediated dilation of brachial artery19214.6±3.05.3±3.10.32 (−1.88 to 2.53)0.9
Lifestyle interventions
Flesher et al 39 Composite of eGFR, TC, US, UP, BPNumber of improved endpoints231783300.028
Howden et al 40 Change in CRFVO2, ml/kg/min36362.8±0.70.3±0.90.004
Ishani et al 41 Composite death, hospitalisation, emergency visits, admission nursing facilityOccurrence of primary outcome/HR451150208 (46.2%)70 (46.7%)0.9
Jiamjariyapon et al 67 Mean change in eGFRChange eGFR, mL/min/1.73 m2 23420842.4±1.539.9±2.82.74 (0.60 to 4.50)0.009
Joboshi and Oka44 Perceived behaviourSelf-efficacy3229r=0.27, U=318.5** 0.035
Self-managementr=0.29, U=310.0** 0.026
Patil et al 68 24-hour urine protein24-hour urine protein, g/d23 (B)22 (A),31 (C)1284.74±1079.94A: 1079.27±1269.20; C: 1187.61±756.92
BMIChange in BMI (paired t-test)−1.95±1.10A: −0.15±0.38 (p=0.069); C: −2.56±0.68 (p=0.000)0.000
Teng et al 31 Health-promotion lifestyleStress management45452.760.10
behaviours (HPLP-IIC)Interpersonal relations3.880.05
Health responsibility13.630.001
Physical activity7.500.01
Spiritual growth2.790.10
Nutrition2.620.11
Renal function protection knowledgeKnowledge renal function, Chinese herbs and CKD dietNo data0.001
Physical function6MWT, minutes4545420.4±81.2368.5±99.70.04

*Unless otherwise indicated, values are shown as mean+/-SD.

†Mean change (95% CI).

‡Modification of Diet in Renal Disease (MDRD) study (Gillis et al 33, Coyne et al 48).

§Mean decline +/-SD.

¶Mean change from baseline after 6 months.

**Effect size (r) Median, Mann-Whitney's U Test.

††Mean change and % reduction from baseline values.

‡‡ Number of participants who met adherence criteria (n,%).

§§Paired T test.

¶¶ p-value calculated as p<0.05 x group interaction (Aoike 2015).

***STST results standardized as a percentage of age-predicted value using prediction formulas (Rossi 2014).

†††Median (IQR)

BMI, Body Mass Index; BP, blood pressure;CrCl, Creatinine clearance; CRF, Cardiorespiratory fitness; eGFR, estimated glomerular filtration rate; HAD-A/HAD-D, Hospital Anxiety & Depression Scale; HPLP-IIC, Health Promoting Lifestyle Profile-II Chinese version (questionnaire); KDQOL-SF, Kidney Disease & Quality of Life Short Form; 6MWT, 6 min Walk Test; SF-12 PCS/MCS, Physical and Mental Health Composite Scores; QoL, Quality of life; RAND SF-36, 36-Item Short Form Survey; STST, Sit to Stand Test; SUN, Serum urea nitrogen; UP, Urinary protein; UPCR, Urine protein to creatinine ratio; US, Urinary sodium; UUN, urinary urea nitrogen.

Effects of the behaviour change interventions on the primary outcome(s) *Unless otherwise indicated, values are shown as mean+/-SD. †Mean change (95% CI). ‡Modification of Diet in Renal Disease (MDRD) study (Gillis et al 33, Coyne et al 48). §Mean decline +/-SD. ¶Mean change from baseline after 6 months. **Effect size (r) Median, Mann-Whitney's U Test. ††Mean change and % reduction from baseline values. ‡‡ Number of participants who met adherence criteria (n,%). §§Paired T test. ¶¶ p-value calculated as p<0.05 x group interaction (Aoike 2015). ***STST results standardized as a percentage of age-predicted value using prediction formulas (Rossi 2014). †††Median (IQR) BMI, Body Mass Index; BP, blood pressure;CrCl, Creatinine clearance; CRF, Cardiorespiratory fitness; eGFR, estimated glomerular filtration rate; HAD-A/HAD-D, Hospital Anxiety & Depression Scale; HPLP-IIC, Health Promoting Lifestyle Profile-II Chinese version (questionnaire); KDQOL-SF, Kidney Disease & Quality of Life Short Form; 6MWT, 6 min Walk Test; SF-12 PCS/MCS, Physical and Mental Health Composite Scores; QoL, Quality of life; RAND SF-36, 36-Item Short Form Survey; STST, Sit to Stand Test; SUN, Serum urea nitrogen; UP, Urinary protein; UPCR, Urine protein to creatinine ratio; US, Urinary sodium; UUN, urinary urea nitrogen. Eighteen studies (69%) showed a significant improvement in at least one primary outcome and all of these studies included education, persuasion, modelling and incentivisation as an intervention function (see online supplementary table S3). A meta-analysis of the data was not possible due to heterogeneity of outcome measures across the included studies. The heterogeneity of outcomes also meant we could not link outcomes with specific behaviour change techniques. Many studies are likely to be underpowered to detect modest effects, and so the absence of a statistically significant effect should not be regarded as evidence of no effect.

Discussion

Behaviour change interventions in trials in patients with CKD mostly focused on diet and physical activity. The primary outcomes of the trials were diverse and most were biochemical outcomes (eg, eGFR, blood pressure, peak VO2 and sodium or albumin excretion), with few clinical or patient-reported and/or behavioural outcomes such as quality of life, fatigue, knowledge, self-efficacy and self-management.30 31 38 39 44 45 Only five interventions were underpinned by theory. The most frequently used intervention function was education, followed by enablement and training. Persuasion, environmental restructuring, modelling and incentivisation were used less frequently. Coercion and restrictions (which includes regulation) were not used in any of the studies. The top five most common behaviour change techniques were instruction on how to perform the behaviour, social support, demonstration of the behaviour, feedback on behaviour and behavioural practice/rehearsal. Identity, scheduled consequences and covert learning were not used in any of the studies. No association between frequency of functions or behaviour change techniques and the effect of interventions on outcomes could be identified. The use of multiple behaviour change techniques does not necessarily lead to better outcomes and some evidence suggests that fewer techniques and the right combinations of techniques suited to the context are more effective.50–52 Education was the most frequent intervention function used across the studies, which may be because it has been consistently shown that patients with CKD lack awareness about lifestyle risk factors and have low health literacy.10 11 53 Specifically, the behaviour change technique, ‘instruction on how to perform the behaviour’, was the most frequently reported technique, used in all interventions except two. We suggest this is highly applicable because dietary interventions can involve complex dietary restrictions of sodium, protein, potassium and phosphate. Patients have sought practical advice about how to implement these restrictions.54 However, most educational strategies used a didactic approach, with health professionals verbally conveying information or providing written materials. Patients with CKD prefer multiple problem-solving and collaborative approaches, in partnership with health professionals.54 Also, written materials for patients with CKD have a reading grade of 9 (age 14–15 years), which is higher than the recommended level (grade 5).10 The intervention function ‘training’ was used in every study targeting physical activity but was only used in two dietary interventions. Patients with CKD are overwhelmed by dietary information which can be complex, restrictive and insensitive to cultural norms.54 A recent review of educational interventions for CKD patients found that including practical skills and workshops was associated with better outcomes.55 For example, a low-salt programme for Bangladeshi patients with CKD in the United Kingdom included cooking and educational sessions facilitated by Bengali workers in a community kitchen. It targeted both patients and family members who cooked their own low-salt version of Bangladeshi recipes and led to a reduction in salt intake and reduced blood pressure for participants.37 Approaches to enabling and training patients for behaviour change incorporating hands-on training may be more effective. Our findings are similar to recent reviews of behavioural interventions for other conditions (cardiovascular disease, obesity, rheumatoid arthritis, prostate cancer and diabetes), which also found that behavioural interventions are not well-reported, not informed by theory and have diverse outcomes and modes of delivery.25–27 51 56 The behaviour change techniques associated with goals and planning, feedback and monitoring and social support have also been frequently used in behaviour changes interventions in patients with other chronic conditions. These techniques are proven strategies for behaviour change and in line with evidence-based recommendations for lifestyle modification.12 13 57 We identified and described the behaviour change techniques and intervention functions in lifestyle behavioural interventions for patients with CKD with comprehensive evidence-based frameworks. Coding of behaviour change techniques and intervention functions was systematically and independently conducted by three researchers, and risk of bias was assessed. Potential limitations relate to poor reporting. Some interventions may have used behaviour change techniques or intervention functions in their study but did not report them, or details of techniques were unclear. We contacted authors and examined all associated supplementary materials and papers to collect more information. Lifestyle behaviour change interventions for patients with CKD appear to integrate recommended and proven behaviour change techniques and intervention functions. These techniques such as goals and planning and self-monitoring are important but focus on individual agency rather than external factors. Interventions could be improved by considering the context of behaviour change and the social and physical environment of participants. For example, most of the interventions for physical activity focused on structured exercise programme and a reliance on equipment (eg, exercise bikes). Patients with CKD need to be able to integrate physical activity in to their daily lifestyle.58 However, only one intervention for physical activity gave instructions on how to incorporate physical activity to fit in with daily activities and in environments easily accessible to patients, without the use of equipment.59 This study reported improvements in cardiopulmonary and functional capacities of overweight patients with CKD. Optimising the social environment and arranging support from friends, family and the community may also improve lifestyle behaviour change interventions for patients with CKD. Family support was used rarely in interventions in this review and only included in two studies.31 37 However, informal caregivers play an important role in the management of CKD and are often required to change their own lifestyle behaviours to support patients with CKD.60 Characteristics of effective educational interventions for patients with CKD involved the patient’s family.55 The quality of the design and reporting of lifestyle behaviour change interventions for patients with CKD requires explicit description of behavioural strategies to ensure interventions are generalisable and replicable. There are numerous evidence-based guidelines that recommend the explicit use of behaviour change techniques for addressing lifestyle risk factors in chronic disease prevention and these may be better used when designing and reporting interventions for patients with CKD. Recently the National Institute of Health and Care Excellence in the UK published comprehensive guidelines specific to behavioural interventions and lifestyle modification.12 The WHO’s recommendations on behaviour change support this and further reinforce the need to consider the social and environmental determinants of health in changing lifestyle behaviours.57

Conclusion

Lifestyle interventions in trials conducted in patients with CKD mostly focus on goals and planning, feedback and monitoring and education. However, we suggest that interventions may be improved by using interactive and tailored training, and strategies to help patients incorporate lifestyle modification in their daily activities, and physical and social environments. Explicit application of behaviour change taxonomies may help to increase the effect of lifestyle behaviour change interventions for improved health outcomes in patients with CKD.
  61 in total

Review 1.  Readability of Written Materials for CKD Patients: A Systematic Review.

Authors:  Suzanne Morony; Michaela Flynn; Kirsten J McCaffery; Jesse Jansen; Angela C Webster
Journal:  Am J Kidney Dis       Date:  2015-02-04       Impact factor: 8.860

2.  Effects of individualized exercise program on physical function, psychological dimensions, and health-related quality of life in patients with chronic kidney disease: A randomized controlled trial in China.

Authors:  Qing Tang; Bin Yang; Fengyan Fan; Ping Li; Lei Yang; Yujie Guo
Journal:  Int J Nurs Pract       Date:  2017-02-19       Impact factor: 2.066

Review 3.  Dietary and fluid restrictions in CKD: a thematic synthesis of patient views from qualitative studies.

Authors:  Suetonia C Palmer; Camilla S Hanson; Jonathan C Craig; Giovanni F M Strippoli; Marinella Ruospo; Katrina Campbell; David W Johnson; Allison Tong
Journal:  Am J Kidney Dis       Date:  2014-11-06       Impact factor: 8.860

4.  Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial.

Authors:  Amaryllis H Van Craenenbroeck; Emeline M Van Craenenbroeck; Katrijn Van Ackeren; Christiaan J Vrints; Viviane M Conraads; Gert A Verpooten; Evangelia Kouidi; Marie M Couttenye
Journal:  Am J Kidney Dis       Date:  2015-05-08       Impact factor: 8.860

5.  Exercise in patients with hypertension and chronic kidney disease: a randomized controlled trial.

Authors:  Franklin C Barcellos; Fabricio Boscolo Del Vecchio; Annelise Reges; Gregore Mielke; Iná S Santos; Daniel Umpierre; Maristela Bohlke; Pedro C Hallal
Journal:  J Hum Hypertens       Date:  2018-04-04       Impact factor: 3.012

Review 6.  A Systematic Review of the Prevalence and Associations of Limited Health Literacy in CKD.

Authors:  Dominic M Taylor; Simon D S Fraser; J Andrew Bradley; Clare Bradley; Heather Draper; Wendy Metcalfe; Gabriel C Oniscu; Charles R V Tomson; Rommel Ravanan; Paul J Roderick
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-09       Impact factor: 8.237

Review 7.  Behaviour change techniques in home-based cardiac rehabilitation: a systematic review.

Authors:  Neil Heron; Frank Kee; Michael Donnelly; Christopher Cardwell; Mark A Tully; Margaret E Cupples
Journal:  Br J Gen Pract       Date:  2016-08-01       Impact factor: 5.386

8.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

9.  The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial.

Authors:  Ione de Brito-Ashurst; Lin Perry; Thomas A B Sanders; Jane E Thomas; Hamish Dobbie; Mira Varagunam; Muhammad M Yaqoob
Journal:  Heart       Date:  2013-06-13       Impact factor: 5.994

10.  Weight loss for reduction of proteinuria in diabetic nephropathy: Comparison with angiotensin-converting enzyme inhibitor therapy.

Authors:  M R Patil; A Mishra; N Jain; M Gutch; R Tewari
Journal:  Indian J Nephrol       Date:  2013-03
View more
  8 in total

1.  Clinical practice guideline exercise and lifestyle in chronic kidney disease.

Authors:  Luke A Baker; Daniel S March; Thomas J Wilkinson; Roseanne E Billany; Nicolette C Bishop; Ellen M Castle; Joseph Chilcot; Mark D Davies; Matthew P M Graham-Brown; Sharlene A Greenwood; Naushad A Junglee; Archontissa M Kanavaki; Courtney J Lightfoot; Jamie H Macdonald; Gabriella M K Rossetti; Alice C Smith; James O Burton
Journal:  BMC Nephrol       Date:  2022-02-22       Impact factor: 2.388

2.  Psychosocial barriers and facilitators for adherence to a healthy lifestyle among patients with chronic kidney disease: a focus group study.

Authors:  Cinderella K Cardol; Karin Boslooper-Meulenbelt; Henriët van Middendorp; Yvette Meuleman; Andrea W M Evers; Sandra van Dijk
Journal:  BMC Nephrol       Date:  2022-06-11       Impact factor: 2.585

Review 3.  Nutrition Education Programs for Adults with Neurological Diseases Are Lacking: A Scoping Review.

Authors:  Rebecca D Russell; Lucinda J Black; Andrea Begley
Journal:  Nutrients       Date:  2022-04-10       Impact factor: 6.706

Review 4.  Renal Rehabilitation: Exercise Intervention and Nutritional Support in Dialysis Patients.

Authors:  Junichi Hoshino
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

5.  Therapeutic effects of exercise interventions for patients with chronic kidney disease: protocol for an overview of systematic reviews and meta-analyses of clinical trials.

Authors:  Fan Zhang; Hui Wang; Liuyan Huang; Huachun Zhang
Journal:  BMJ Open       Date:  2021-02-11       Impact factor: 2.692

6.  Group-Based Exercise in CKD Stage 3b to 4: A Randomized Clinical Trial.

Authors:  Shuchi Anand; Susan L Ziolkowski; Ahad Bootwala; Jianheng Li; Nhat Pham; Jason Cobb; Felipe Lobelo
Journal:  Kidney Med       Date:  2021-07-08

7.  A Lifestyle Intervention to Delay Early Chronic Kidney Disease in African Americans With Diabetic Kidney Disease: Pre-Post Pilot Study.

Authors:  Mukoso N Ozieh; Leonard E Egede
Journal:  JMIR Form Res       Date:  2022-03-15

8.  Comparison of Human Urinary Exosomes Isolated via Ultracentrifugation Alone versus Ultracentrifugation Followed by SEC Column-Purification.

Authors:  Kun Huang; Sudha Garimella; Alyssa Clay-Gilmour; Lucia Vojtech; Bridget Armstrong; Madison Bessonny; Alexis Stamatikos
Journal:  J Pers Med       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.